Cel
The overall aim of Predict-IV is to develop strategies to improve the assessment of drug safety in the early stage of development and late discovery phase, by an intelligent combination of non animal-based test systems, cell biology, mechanistic toxicology and in-silico modelling, in a rapid and cost effective manner. A better prediction of the safety of an investigational compound in early development will be delivered. Margins-of-safety will be deduced and the data generated by the proposed approach may also identify early biomarkers of human toxicity for pharmaceuticals. The results obtained in Predict-IV will enable pharmaceutical companies to create a tailored testing strategy for early drug safety. The project will integrate new developments to improve and optimize cell culture models for toxicity testing and to characterize the dynamics and kinetics of cellular responses to toxic effects in vitro. The target organs most frequently affected by drug toxicity will be taken into account, namely liver and kidney. Moreover, predictive models for neurotoxicty are scarce and will be developed. For each target organ the most appropriate cell model will be used. The approach will be evaluated using a panel of drugs with well described toxicities and kinetics in animals and partly also in humans. This approach will be highly advantageous as it will allow a direct comparison between the in vivo to the in vitro data. A parallel analysis of several dynamic and kinetic models with a broad spectrum of endpoints should allow for the identification of several relevant biomarkers of toxicity. Inter-individual susceptibilities will be taken into account by integrating the polymorphisms of the major drug metabolizing enzymes and correlating the observed effects in the human cell models with their genotype. Environmental influences on cellular toxicity to these compounds will also be evaluated using hypoxic stress as a relevant test model.
Dziedzina nauki
Not validated
Not validated
- medical and health sciencesbasic medicinepharmacology and pharmacydrug safety
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- natural sciencesbiological sciencescell biology
- medical and health sciencesbasic medicinetoxicology
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsenzymes
Słowa kluczowe
Zaproszenie do składania wniosków
FP7-HEALTH-2007-A
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-IP - Large-scale integrating projectKoordynator
97070 Wuerzburg
Niemcy
Zobacz na mapie
Uczestnicy (19)
64293 DARMSTADT
Zobacz na mapie
6020 Innsbruck
Zobacz na mapie
00161 Roma
Zobacz na mapie
60550 Verneuil En Halatte
Zobacz na mapie
1049 Bruxelles / Brussel
Zobacz na mapie
1180 Wien
Zobacz na mapie
4056 Basel
Zobacz na mapie
67115 Plobsheim
Zobacz na mapie
35065 RENNES CEDEX
Zobacz na mapie
4 Dublin
Zobacz na mapie
3584 CS Utrecht
Zobacz na mapie
EC2Y 5EB London
Zobacz na mapie
14195 Berlin
Zobacz na mapie
1015 LAUSANNE
Zobacz na mapie
62000 Arras
Zobacz na mapie
69120 Heidelberg
Zobacz na mapie
18055 Rostock
Zobacz na mapie
18119 ROSTOCK
Zobacz na mapie
5020 Salzburg
Zobacz na mapie